Genetic DAO Deficiency and Lower Urinary Tract Symptoms

Sex: All

Ages: 18 Years – N/A

Enrollment: 100

Sponsor: Complexo Hospitalario Universitario de A Coruña

Summary

The aim of this study is to determinate the prevalence os genetic DAO deficiency in patients with lower urinary tract symptoms.

Eligibility Criteria

Inclusion Criteria:CACV socre > 3 and/orIPSS score > 7Exclusion Criteria:Pharmacological treatment for LUTS in the 2 weeks prior to study inclusion (anticholinergics, antimuscarinics, or betamimetics).History of previous bladder and/or prostate surgery.History of bladder tumor in the previous 3 months.History of intravesical chemotherapy in the previous 3 months.Active urinary tract infection in the previous 2 weeks.Antihistamine treatmentHistory of colorectal surgery and/or previous abdomino-perineal amputation.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05676346). StuddyBuddy aggregates publicly available trial information.